PINAVERIUM 50 MG
PINAVERIUM BROMIDE : 50 MG · DIN 02469677 · AA PHARMA INC
Health Canada status: MARKETED
What is PINAVERIUM?
PINAVERIUM 50 MG contains PINAVERIUM BROMIDE : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 02469677, held by AA PHARMA INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 16-Aug-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is PINAVERIUM used for?
PINAVERIUM (pinaverium bromide) is indicated for the treatment and relief of symptoms associated with irritable bowel syndrome (IBS): abdominal pain, bowel disturbances and intestinal discomfort; and for the treatment of symptoms related to functional disorders of the biliary tract.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02469677 |
|---|---|
| Brand name | PINAVERIUM |
| Generic / active ingredient | PINAVERIUM BROMIDE : 50 MG |
| Manufacturer | AA PHARMA INC |
| Strength | 50 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | A03AX04 PINAVERIUM |
| AHFS class | 56:92.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 16-Aug-2021 |
| Original market date | 2018-09-13 00:00:00 |
How is it stored and handled?
controlled room temperature, 15°C to 25°C and protect from moisture
How is it supplied?
50 mg Film-coated Tablets: Available in blisters 100’s (10 x 10) and HDPE bottles of 100 tablets. 100 mg Film-coated Tablets: Available in blisters 100’s (10 x 10) and HDPE bottles of 100 tablets.
What can be used instead?
Other Canadian products sharing ATC code A03AX04 PINAVERIUM. 4 of 4 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| DICETEL | 100 MG | TABLET | BGP PHARMA ULC | MARKETED | DIN 02230684 |
| DICETEL | 50 MG | TABLET | BGP PHARMA ULC | MARKETED | DIN 01950592 |
| PINAVERIUM | 100 MG | TABLET | AA PHARMA INC | MARKETED | DIN 02469685 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.